FDA Inspection 1317060 — Benjamin Besse, M.D., Ph.D.
The FDA completed an inspection of Benjamin Besse, M.D., Ph.D. on April 24, 2026 in Villejuif. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 24, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Villejuif (France)
Additional Details
Clinical Investigator (CI)